Squarepoint’s Cross Country Healthcare CCRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $987K | Buy |
105,042
+94,024
| +853% | +$842K | ﹤0.01% | 2790 |
|
|
2025
Q4 | $89.2K | Sell |
11,018
-74,338
| -87% | -$812K | ﹤0.01% | 4053 |
|
|
2025
Q3 | $1.21M | Buy |
85,356
+49,942
| +141% | +$660K | ﹤0.01% | 2521 |
|
|
2025
Q2 | $462K | Sell |
35,414
-199,062
| -85% | -$2.74M | ﹤0.01% | 3338 |
|
|
2025
Q1 | $3.49M | Sell |
234,476
-20,886
| -8% | -$359K | ﹤0.01% | 1673 |
|
|
2024
Q4 | $4.64M | Buy |
255,362
+213,416
| +509% | +$2.87M | ﹤0.01% | 1698 |
|
|
2024
Q3 | $564K | Buy |
41,946
+29,386
| +234% | +$433K | ﹤0.01% | 3003 |
|
|
2024
Q2 | $174K | Buy |
+12,560
| New | +$199K | ﹤0.01% | 3696 |
|
|
2023
Q3 | – | Sell |
-10,932
| Closed | -$307K | – | 3827 |
|
|
2023
Q2 | $307K | Buy |
+10,932
| New | +$271K | ﹤0.01% | 2953 |
|
|
2023
Q1 | – | Sell |
-16,447
| Closed | -$437K | – | 3279 |
|
|
2022
Q4 | $437K | Sell |
16,447
-47,933
| -74% | -$1.56M | ﹤0.01% | 2359 |
|
|
2022
Q3 | $1.83M | Buy |
64,380
+40,792
| +173% | +$1.05M | 0.01% | 1376 |
|
|
2022
Q2 | $491K | Buy |
+23,588
| New | +$442K | ﹤0.01% | 2024 |
|
|
2022
Q1 | – | Sell |
-17,352
| Closed | -$482K | – | 2882 |
|
|
2021
Q4 | $482K | Buy |
17,352
+7,342
| +73% | +$178K | ﹤0.01% | 2169 |
|
|
2021
Q3 | $213K | Sell |
10,010
-32,308
| -76% | -$606K | ﹤0.01% | 2449 |
|
|
2021
Q2 | $699K | Sell |
42,318
-21,156
| -33% | -$323K | ﹤0.01% | 1893 |
|
|
2021
Q1 | $793K | Buy |
63,474
+8,332
| +15% | +$88.3K | ﹤0.01% | 1691 |
|
|
2020
Q4 | $489K | Buy |
55,142
+16,889
| +44% | +$137K | ﹤0.01% | 1826 |
|
|
2020
Q3 | $248K | Buy |
38,253
+8,373
| +28% | +$53.1K | ﹤0.01% | 1958 |
|
|
2020
Q2 | $184K | Sell |
29,880
-20,464
| -41% | -$126K | ﹤0.01% | 1840 |
|
|
2020
Q1 | $339K | Buy |
50,344
+1,445
| +3% | +$13.7K | 0.01% | 1242 |
|
|
2019
Q4 | $568K | Buy |
48,899
+15,230
| +45% | +$172K | ﹤0.01% | 1697 |
|
|
2019
Q3 | $347K | Buy |
33,669
+6,182
| +22% | +$60.8K | ﹤0.01% | 1820 |
|
|
2019
Q2 | $258K | Buy |
27,487
+11,343
| +70% | +$87.3K | ﹤0.01% | 1990 |
|
|
2019
Q1 | $113K | Sell |
16,144
-71,263
| -82% | -$611K | ﹤0.01% | 2024 |
|
|
2018
Q4 | $641K | Buy |
87,407
+30,608
| +54% | +$257K | 0.01% | 1126 |
|
|
2018
Q3 | $496K | Buy |
56,799
+13,612
| +32% | +$139K | 0.01% | 1302 |
|
|
2018
Q2 | $486K | Buy |
+43,187
| New | +$515K | 0.01% | 1202 |
|
|
2018
Q1 | – | Sell |
-13,480
| Closed | -$172K | – | 1725 |
|
|
2017
Q4 | $172K | Buy |
13,480
+58
| +0.4% | +$766 | ﹤0.01% | 1837 |
|
|
2017
Q3 | $191K | Buy |
+13,422
| New | +$168K | ﹤0.01% | 1401 |
|
|
2016
Q3 | – | Sell |
-11,596
| Closed | -$161K | – | 1027 |
|
|
2016
Q2 | $161K | Buy |
+11,596
| New | +$154K | 0.01% | 928 |
|
Other funds holding CCRN
VCM
SCM
QOP
OBAM
DIA
Squarepoint's CCRN Position: Q1 2026 in Review
Squarepoint increased its Cross Country Healthcare (CCRN) stake by 853% in Q1 2026, buying an estimated $842K and bringing the position to 105,042 shares worth $987K. The position accounts for ﹤0.01% of the portfolio, ranked #2790.
Squarepoint first reported a position in CCRN in Q2 2016 and has held it in 30 quarters since. The position peaked at $4.64M in Q4 2024. 151 funds tracked by Wall St. Rank hold CCRN as of Q1 2026.
- Squarepoint held 105,042 shares of Cross Country Healthcare worth $987K as of Q1 2026.
- Squarepoint bought 94,024 Cross Country Healthcare shares in Q1 2026, an estimated $842K.
- Cross Country Healthcare made up ﹤0.01% of Squarepoint's portfolio in Q1 2026, its #2790 holding.
- Squarepoint first reported a position in Cross Country Healthcare in Q2 2016 and has held it in 30 quarters since.
- Squarepoint's Cross Country Healthcare position peaked at $4.64M in Q4 2024.
- 151 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2026.
Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.